A Search for a New Cellular Model to Study the Pharmacological Activity of Progesterone Analogues


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The possibility of using the endometrial cell line as a model for studying the pharmacological activity of progesterone analogues is considered. Conditions for obtaining and culturing of endometrial cell lines are described, the morphological characteristic is given, and the immunophenotypic profile, karyotype, and expression of progesterone and estrogen receptors are presented. Not all studied endometrial lines showed the ability to decidualize cells under the action of hormonal inducers (combinations of estradiol with progesterone and its analogues). It appeared that lines sensitive to hormones are able to increase the secretion of specific markers of decidualization under the action of highly active gestagenes (progesterone analogues) to a greater extent than under action of progesterone. These data are a basis for further development of the cellular model for studying the pharmacological activity of gestagenic compounds.

About the authors

M. A. Petrosyan

Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott

Author for correspondence.
Email: mariya@labpharm.spb.ru
Russian Federation, St. Petersburg, 199034

N. O. Melezhnikova

Peter the Great St. Petersburg Polytechnic University

Email: mariya@labpharm.spb.ru
Russian Federation, St. Petersburg, 195251

A. P. Domnina

Institute of Cytology of the Russian Academy of Sciences

Email: mariya@labpharm.spb.ru
Russian Federation, St. Petersburg, 194064

V. A. Andryushina

Federal Research Center “Fundamentals of Biotechnology” of the Russian Academy of Sciences

Email: mariya@labpharm.spb.ru
Russian Federation, Moscow, 117312

T. S. Goryachaya

Institute of Cytology of the Russian Academy of Sciences

Email: mariya@labpharm.spb.ru
Russian Federation, St. Petersburg, 194064

L. I. Petrova

Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott

Email: mariya@labpharm.spb.ru
Russian Federation, St. Petersburg, 199034

O. V. Malysheva

Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott

Email: mariya@labpharm.spb.ru
Russian Federation, St. Petersburg, 199034

A. V. Razygraev

Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott; St. Petersburg State Chemical Pharmaceutical Academy

Email: mariya@labpharm.spb.ru
Russian Federation, St. Petersburg, 199034; St. Petersburg, 197376

V. O. Polyakova

Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott

Email: mariya@labpharm.spb.ru
Russian Federation, St. Petersburg, 199034

N. S. Sapronov

Institute of Experimental Medicine

Email: mariya@labpharm.spb.ru
Russian Federation, St. Petersburg, 197376

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Pleiades Publishing, Ltd.